Evidence map›Paper›PMID 29660316›Full record

ArticleCryobiology2018

Vitrification tendency and stability of DP6-based vitrification solutions for complex tissue cryopreservation.

Brian Wowk, Gregory M Fahy, Susan Ahmedyar, Michael J Taylor, Yoed Rabin

Abstract read
In one paragraph

Article in Cryobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Cryopreservation of biological materials: applications and economic perspectives.In vitro cellular & developmental biology. Animal · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Principles of Ice-Free Cryopreservation by Vitrification.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. New Approaches to Cryopreservation of Cells, Tissues, and Organs.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Brian Wowk21st Century Medicine, Inc., Fontana, CA 92336, United States. Electronic address: wowk@21cm.com.
Gregory M Fahy21st Century Medicine, Inc., Fontana, CA 92336, United States.
Susan Ahmedyar21st Century Medicine, Inc., Fontana, CA 92336, United States.
Michael J TaylorDepartment of Mechanical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, United States; Tissue Testing Technologies LLC, North Charleston, SC 29406, United States.
Yoed RabinDepartment of Mechanical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, United States.

Funding

Cryopreservation mechanisms in blood vessels using ice modulatorsR01HL127618 · NHLBI · CARNEGIE-MELLON UNIVERSITY · PI RABIN, YOED · 2015 to 2018
$1.6M
NHLBI NIH HHS R01 HL127618
6 · The paper itself

Abstract

Vitrification tendency and stability of the amorphous state were analyzed by means of differential scanning calorimetry (DSC) for the vitrification solution DP6, with and without additional solutes to enhance ice suppression. This study is a part of an ongoing research effort to characterize the thermophysical and mechanical properties of DP6 and its derivatives, and their qualities as cryoprotective solutions. DP6 was determined to have a critical cooling rate necessary to ensure vitrification of 2.7 °C/min. The following additional solutions were tested: DP6 + 6% (2R, 3R) 2,3-butanediol, DP6 + 6% 1,3-cyclohexanediol, DP6 + 6% (0.175M) sucrose, DP6 + 12% PEG 400, and DP6 + 17.1% (0.5 M) sucrose. The additives decreased the critical cooling rate of the DP6 solution to rates below 1 °C/min that were not quantifiable by the DSC techniques used. The following critical warming rates necessary to avoid devitrification were identified for DP6 and the modified solutions, respectively: 189 °C/min, 5 °C/min, ≈ 1 °C/min, 15 °C/min, <1 °C/min, and <1 °C/min. Glass transition temperatures and melting temperatures were also measured. Sucrose was the least effective additive on a per mass basis, with 1,3-cyclohexanediol appearing to be the most effective additive for suppressing ice formation in DP6.

Indexed as

VitrificationAnimalsButylene GlycolsCalorimetry, Differential ScanningCold TemperatureCryopreservationCryoprotective AgentsCyclohexanolsDimethyl SulfoxideHEPESPhase TransitionPolyethylene GlycolsPropylene GlycolsSucroseTransition TemperatureButylene GlycolsCryoprotective Agentscyclohexane-1,3-diolCyclohexanolsDimethyl SulfoxideDP6 solutionHEPESpolyethylene glycol 400Polyethylene GlycolsPropylene GlycolsSucroseCryopreservationDP6DSCSynthetic ice modulatorVitrification

Identifiers

PMID29660316
PMCPMC6896785

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.